Empowering Patient Voice in Epilepsy Treatment and Strategies for Seizure Freedom: Patrick Kwan, MD, PhD, FRCP
The professor of neurology in the department of neuroscience at Monash University discussed implementation strategies for treatment approaches to achieve seizure freedom in patients with epilepsy. [WATCH TIME: 5 minutes]
WATCH TIME: 5 minutes
"Seizure freedom consistently improves the patient's quality of life, reduces comorbidities, or even mortality. Patients tell us that achieving seizure freedom is crucial. For those newly diagnosed, uncertainties about achieving seizure freedom create a sense of vulnerability, putting life on hold for both the patient and their families."
Epilepsy encompasses a wide variety of medical conditions that are characterized by recurrent seizures. In epilepsy care, achieving seizure freedom is the primary objective, which is endorsed by patients, families, and even treatment guidelines because of its substantial enhancement of quality of life.1 Managing epilepsy though poses several challenges because of the multitude of syndromes, seizure types, and individual responses to therapies. Despite the present challenges, recent strides in genetic testing offer updated strategies for diagnosing specific epileptic disorders and tailoring treatments.2 Looking ahead, the trajectory of epilepsy treatment suggests a shift from the current empirical approach to precision medicine, like therapies for drug-resistant epilepsy, potentially transforming the landscape of care.
At the
Prior to the symposium, one of the speakers
REFERENCES
1. Striano P, Minassian BA. From Genetic Testing to Precision Medicine in Epilepsy. Neurotherapeutics. 2020;17(2):609-615. doi:10.1007/s13311-020-00835-4
2. Halford JJ, Edwards JC. Seizure freedom as an outcome in epilepsy treatment clinical trials. Acta Neurol Scand. 2020;142(2):91-107. doi:10.1111/ane.13257
3. SK Life Science to Host Symposium and Present New Data at the American Epilepsy Society (AES) 2023 Annual Meeting. News Release. SK Life Science. Published November 28, 2023. Accessed November 30, 2023. https://www.prnewswire.com/news-releases/sk-life-science-to-host-symposium-and-present-new-data-at-the-american-epilepsy-society-aes-2023-annual-meeting-301998374.html
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Pathophysiology of Myasthenia Gravis
September 18th 2025